CTI BioPharma Corp. (CTIC): Price and Financial Metrics
GET POWR RATINGS... FREE!
CTIC Stock Price Chart Interactive Chart >
CTIC Price/Volume Stats
|Current price||$5.99||52-week high||$6.52|
|Prev. close||$6.08||52-week low||$1.43|
|Day high||$5.99||Avg. volume||4,702,724|
|50-day MA||$5.29||Dividend yield||N/A|
|200-day MA||$3.51||Market Cap||652.71M|
CTI BioPharma Corp. (CTIC) Company Bio
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. The company was founded in 1991 and is based in Seattle, Washington.
Most Popular Stories View All
CTIC Latest News Stream
|Loading, please wait...|
CTIC Latest Social Stream
View Full CTIC Social Stream
Latest CTIC News From Around the Web
Below are the latest news stories about Cti Biopharma Corp that investors may wish to consider to help them evaluate CTIC as an investment opportunity.
CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company's Amended and Restated 2017 Equity Incentive Plan (but under the terms of the Amended and Restated 2017 Equity Incentive Plan) and material to the employee's acceptance of employment with the company. The equity award was approved on January 5, 2022, in accordance w
CTI BioPharma Corp. (NASDAQ:CTIC)s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $2.34. CTI BioPharma shares last traded at $2.29, with a volume of 821,009 shares traded. Several research analysts recently issued 
CTI BioPharma Corp. (NASDAQ:CTIC) traded at $2.30 at close of the session on Tuesday, 12/21/21, made a downward move of -0.43% on its previous days price. Looking at the stock we see that its previous close was $2.31 and the beta (5Y monthly) reads 0.69 with the days price range being $2.26 $2.385. In Wall Streets Take On CTI BioPharma Corp. (NASDAQ: CTIC) Stock. Read More »
CTI BioPharma Corp. (NASDAQ:CTIC) has a beta value of 0.69 and has seen 1.53 million shares traded in the last trading session. The company, currently valued at $211.48M, closed the last trade at $2.31 per share which meant it gained $0.05 on the day or 2.21% during that session. The CTIC stock price is -78.79% CTI BioPharma Corp. (CTIC) Gains 2.21%, Causing Bears To Win Read More »
CTI BioPharma Corp. (NASDAQ:CTIC) shares, rose in value on Thursday, 12/16/21, with the stock price down by -0.47% to the previous days close as strong demand from buyers drove the stock to $2.14. Actively observing the price movement in the last trading, the stock closed the session at $2.15, falling within a range of $2.095 Understanding CTI BioPharma Corp. (NASDAQ: CTIC)s Growth Potential Read More »
CTIC Price Returns